Literature DB >> 27999839

NIR imaging-guided combined photodynamic therapy and chemotherapy by a pH-responsive amphiphilic polypeptide prodrug.

Zheng Ruan1, Le Liu1, Wei Jiang2, Shuya Li2, Yucai Wang2, Lifeng Yan1.   

Abstract

pH-Sensitive doxorubicin conjugated polymeric micelles entrapped with near infrared (NIR) photosensitizer BODIPY (which works as an imaging agent at the same time) were designed and synthesized by ring opening polymerization of N-carboxyanhydride with mPEG-NH2 as the initiator, following reaction with doxorubicin to form the hydrazone-bond linker for pH responsiveness. Then the NIR dye (BODIPY) was loaded in the micelles for both bioimaging and photodynamic therapy (PDT). A significant cytotoxicity of NIR imaging-guided combined PDT and chemotherapy could be found by MTT assays, which was also confirmed with a fluorescence microscope, indicating a new kind of polymeric nanoparticle for potential theranostic treatment of cancers. In addition, the energy density of the laser for the PDT is extremely low.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27999839     DOI: 10.1039/c6bm00787b

Source DB:  PubMed          Journal:  Biomater Sci        ISSN: 2047-4830            Impact factor:   6.843


  4 in total

1.  Photodynamic therapy at ultra-low NIR laser power and X-Ray imaging using Cu3BiS3 nanocrystals.

Authors:  Srivani Veeranarayanan; M Sheikh Mohamed; Aby Cheruvathoor Poulose; Masuko Rinya; Yasushi Sakamoto; Toru Maekawa; D Sakthi Kumar
Journal:  Theranostics       Date:  2018-10-21       Impact factor: 11.556

Review 2.  Functional Polymer Nanocarriers for Photodynamic Therapy.

Authors:  Tuanwei Li; Lifeng Yan
Journal:  Pharmaceuticals (Basel)       Date:  2018-11-30

Review 3.  Synergic Antitumor Effect of Photodynamic Therapy and Chemotherapy Mediated by Nano Drug Delivery Systems.

Authors:  Mozhgan Aghajanzadeh; Mostafa Zamani; Fereshteh Rajabi Kouchi; Josh Eixenberger; Dorsa Shirini; David Estrada; Farhad Shirini
Journal:  Pharmaceutics       Date:  2022-01-29       Impact factor: 6.321

4.  Targeted delivery of HES5-siRNA with novel polypeptide-modified nanoparticles for hepatocellular carcinoma therapy.

Authors:  Yu Xia; Changbing Wang; Tiantian Xu; Yinghua Li; Min Guo; Zhengfang Lin; Mingqi Zhao; Bing Zhu
Journal:  RSC Adv       Date:  2018-01-09       Impact factor: 3.361

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.